Nevro (NVRO) Tops Q4 EPS by 24c

Go back to Nevro (NVRO) Tops Q4 EPS by 24c

Oppenheimer Downgrades Nevro Corp (NVRO) to Perform, 'unclear path to material growth'

February 22, 2024 6:51 AM EST

Oppenheimer analyst Suraj Kalia downgraded Nevro Corp (NYSE: NVRO) from Outperform to Perform.

The analyst comments "4Q23 revs in line with pre-release ($116M). PDN contribution of $22.4M (+29% y/y, ~+8% seq.). Continued weakness in core SCS (-3% y/y). Ex-PDN, core US SCS... More